| 1. |
- Bravo, L, et al.
(författare)
-
- 2021
-
swepub:Mat__t
|
|
| 2. |
- Tabiri, S, et al.
(författare)
-
- 2021
-
swepub:Mat__t
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Khatri, C, et al.
(författare)
-
Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study
- 2021
-
Ingår i: BMJ open. - : BMJ. - 2044-6055. ; 11:11, s. e050830-
-
Tidskriftsartikel (refereegranskat)abstract
- Studies have demonstrated high rates of mortality in people with proximal femoral fracture and SARS-CoV-2, but there is limited published data on the factors that influence mortality for clinicians to make informed treatment decisions. This study aims to report the 30-day mortality associated with perioperative infection of patients undergoing surgery for proximal femoral fractures and to examine the factors that influence mortality in a multivariate analysis.SettingProspective, international, multicentre, observational cohort study.ParticipantsPatients undergoing any operation for a proximal femoral fracture from 1 February to 30 April 2020 and with perioperative SARS-CoV-2 infection (either 7 days prior or 30-day postoperative).Primary outcome30-day mortality. Multivariate modelling was performed to identify factors associated with 30-day mortality.ResultsThis study reports included 1063 patients from 174 hospitals in 19 countries. Overall 30-day mortality was 29.4% (313/1063). In an adjusted model, 30-day mortality was associated with male gender (OR 2.29, 95% CI 1.68 to 3.13, p<0.001), age >80 years (OR 1.60, 95% CI 1.1 to 2.31, p=0.013), preoperative diagnosis of dementia (OR 1.57, 95% CI 1.15 to 2.16, p=0.005), kidney disease (OR 1.73, 95% CI 1.18 to 2.55, p=0.005) and congestive heart failure (OR 1.62, 95% CI 1.06 to 2.48, p=0.025). Mortality at 30 days was lower in patients with a preoperative diagnosis of SARS-CoV-2 (OR 0.6, 95% CI 0.6 (0.42 to 0.85), p=0.004). There was no difference in mortality in patients with an increase to delay in surgery (p=0.220) or type of anaesthetic given (p=0.787).ConclusionsPatients undergoing surgery for a proximal femoral fracture with a perioperative infection of SARS-CoV-2 have a high rate of mortality. This study would support the need for providing these patients with individualised medical and anaesthetic care, including medical optimisation before theatre. Careful preoperative counselling is needed for those with a proximal femoral fracture and SARS-CoV-2, especially those in the highest risk groups.Trial registration numberNCT04323644
|
|
| 6. |
- Verra, L., et al.
(författare)
-
Development of the self-modulation instability of a relativistic proton bunch in plasma
- 2023
-
Ingår i: Physics of Plasmas. - : American Institute of Physics (AIP). - 1070-664X .- 1089-7674. ; 30:8
-
Tidskriftsartikel (refereegranskat)abstract
- Self-modulation is a beam-plasma instability that is useful to drive large-amplitude wakefields with bunches much longer than the plasma skin depth. We present experimental results showing that, when increasing the ratio between the initial transverse size of the bunch and the plasma skin depth, the instability occurs later along the bunch, or not at all, over a fixed plasma length because the amplitude of the initial wakefields decreases. We show cases for which self-modulation does not develop, and we introduce a simple model discussing the conditions for which it would not occur after any plasma length. Changing bunch size and plasma electron density also changes the growth rate of the instability. We discuss the impact of these results on the design of a particle accelerator based on the self-modulation instability seeded by a relativistic ionization front, such as the future upgrade of the Advanced WAKefield Experiment.
|
|
| 7. |
- Verra, L., et al.
(författare)
-
Filamentation of a relativistic proton bunch in plasma
- 2024
-
Ingår i: Physical review. E. - : American Physical Society. - 2470-0045 .- 2470-0053. ; 109:5
-
Tidskriftsartikel (refereegranskat)abstract
- We show in experiments that a long, underdense, relativistic proton bunch propagating in plasma undergoes the oblique instability, which we observe as filamentation. We determine a threshold value for the ratio between the bunch transverse size and plasma skin depth for the instability to occur. At the threshold, the outcome of the experiment alternates between filamentation and self-modulation instability (evidenced by longitudinal modulation into microbunches). Time-resolved images of the bunch density distribution reveal that filamentation grows to an observable level late along the bunch, confirming the spatiotemporal nature of the instability. We provide a rough estimate of the amplitude of the magnetic field generated in the plasma by the instability and show that the associated magnetic energy increases with plasma density.
|
|
| 8. |
- Nechaeva, T., et al.
(författare)
-
Hosing of a Long Relativistic Particle Bunch in Plasma
- 2024
-
Ingår i: Physical Review Letters. - : American Physical Society. - 0031-9007 .- 1079-7114. ; 132:7
-
Tidskriftsartikel (refereegranskat)abstract
- Experimental results show that hosing of a long particle bunch in plasma can be induced by wakefields driven by a short, misaligned preceding bunch. Hosing develops in the plane of misalignment, selfmodulation in the perpendicular plane, at frequencies close to the plasma electron frequency, and are reproducible. Development of hosing depends on misalignment direction, its growth on misalignment extent and on proton bunch charge. Results have the main characteristics of a theoretical model, are relevant to other plasma -based accelerators and represent the first characterization of hosing.
|
|
| 9. |
- Huang, Hongyun, et al.
(författare)
-
Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)
- 2018
-
Ingår i: Cell Transplantation. - : SAGE Publications. - 0963-6897 .- 1555-3892. ; 27:2, s. 310-324
-
Forskningsöversikt (refereegranskat)abstract
- Cell therapy has been shown to be a key clinical therapeutic option for central nervous system diseases or damage. Standardization of clinical cell therapy procedures is an important task for professional associations devoted to cell therapy. The Chinese Branch of the International Association of Neurorestoratology (IANR) completed the first set of guidelines governing the clinical application of neurorestoration in 2011. The IANR and the Chinese Association of Neurorestoratology (CANR) collaborated to propose the current version "Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)". The IANR council board members and CANR committee members approved this proposal on September 1, 2016, and recommend it to clinical practitioners of cellular therapy. These guidelines include items of cell type nomenclature, cell quality control, minimal suggested cell doses, patient-informed consent, indications for undergoing cell therapy, contraindications for undergoing cell therapy, documentation of procedure and therapy, safety evaluation, efficacy evaluation, policy of repeated treatments, do not charge patients for unproven therapies, basic principles of cell therapy, and publishing responsibility.
|
|
| 10. |
- Haycock, Philip C, et al.
(författare)
-
The association between genetically elevated polyunsaturated fatty acids and risk of cancer.
- 2023
-
Ingår i: EBioMedicine. - : Elsevier. - 2352-3964. ; 91
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: The causal relevance of polyunsaturated fatty acids (PUFAs) for risk of site-specific cancers remains uncertain.METHODS: Using a Mendelian randomization (MR) framework, we assessed the causal relevance of PUFAs for risk of cancer in European and East Asian ancestry individuals. We defined the primary exposure as PUFA desaturase activity, proxied by rs174546 at the FADS locus. Secondary exposures were defined as omega 3 and omega 6 PUFAs that could be proxied by genetic polymorphisms outside the FADS region. Our study used summary genetic data on 10 PUFAs and 67 cancers, corresponding to 562,871 cases and 1,619,465 controls, collected by the Fatty Acids in Cancer Mendelian Randomization Collaboration. We estimated odds ratios (ORs) for cancer per standard deviation increase in genetically proxied PUFA exposures.FINDINGS: Genetically elevated PUFA desaturase activity was associated (P < 0.0007) with higher risk (OR [95% confidence interval]) of colorectal cancer (1.09 [1.07-1.11]), esophageal squamous cell carcinoma (1.16 [1.06-1.26]), lung cancer (1.06 [1.03-1.08]) and basal cell carcinoma (1.05 [1.02-1.07]). There was little evidence for associations with reproductive cancers (OR = 1.00 [95% CI: 0.99-1.01]; Pheterogeneity = 0.25), urinary system cancers (1.03 [0.99-1.06], Pheterogeneity = 0.51), nervous system cancers (0.99 [0.95-1.03], Pheterogeneity = 0.92) or blood cancers (1.01 [0.98-1.04], Pheterogeneity = 0.09). Findings for colorectal cancer and esophageal squamous cell carcinoma remained compatible with causality in sensitivity analyses for violations of assumptions. Secondary MR analyses highlighted higher omega 6 PUFAs (arachidonic acid, gamma-linolenic acid and dihomo-gamma-linolenic acid) as potential mediators. PUFA biosynthesis is known to interact with aspirin, which increases risk of bleeding and inflammatory bowel disease. In a phenome-wide MR study of non-neoplastic diseases, we found that genetic lowering of PUFA desaturase activity, mimicking a hypothetical intervention to reduce cancer risk, was associated (P < 0.0006) with increased risk of inflammatory bowel disease but not bleeding.INTERPRETATION: The PUFA biosynthesis pathway may be an intervention target for prevention of colorectal cancer and esophageal squamous cell carcinoma but with potential for increased risk of inflammatory bowel disease.
|
|
| 11. |
|
|
| 12. |
- Huang, Hongyun, et al.
(författare)
-
The 2022 yearbook of neurorestoratology
- 2023
-
Ingår i: JOURNAL OF NEURORESTORATOLOGY. - : Tsinghua University Press. - 2324-2426. ; 11:2
-
Forskningsöversikt (refereegranskat)abstract
- There was much progress in the field of Neurorestoratology in the year of 2022. It included highlighting advances in understanding the pathogenesis of neurological diseases, neurorestorative mechanisms, and clinical treatments as compiled in the 2022 yearbook of Neurorestoratology. There is still controversy about whether amyloid b-protein and tau protein deposition are the reasons for or the results of Alzheimer's disease (AD) pathology. The fabricated images in important key articles that speculated on the reasons for AD pathogenesis were found. Cholinergic deficiency and decrease or loss in strength of glutamatergic synapse, limited or failing bidirectional cholinergic upregulation in early cognitive impairment, or progressive posterior-to-anterior cortical cholinergic denervation could result in the appearance of AD. Exploration of neurorestorative mechanisms were found in more detail ways in neuromodulation, immunomodulation, neurogenesis, neural network or circuitry reconstruction, neuroprotection, nervous structural repair, and neuroplasticity. Several kinds of cell therapies for neurological diseases showed neurorestorative effects in open-label and/or non-randomized clinical studies or trials. However, mesenchymal stromal cells and mononuclear cells did not demonstrate neurorestorative effects or improve the quality of life for patients with neurodegenerative diseases or neurotrauma including stroke, spinal cord injury (SCI), and amyotrophic lateral sclerosis in randomized, double-blind, placebo-controlled clinical trials (RDPCTs). Clinical treatments through neurostimulation/neuromodulati on and the brain-computer/ machine interface yielded positive results in AD, Parkinson's disease, stroke, SCI, cerebral palsy, and other diseases in RDPCTs. Neurorestorative surgery, pharmaceutical neurorestorative therapy and other interventions have demonstrated neurorestorative effects for various considered incurable neurological diseases in RDPCTs. Thus, this year, additional guidelines, assessment scales, and standards were set up or revised. These included guidelines of clinical neurorestorative treatments for brain trauma (2022 China version), clinical cell therapy guidelines for neurorestoration (IANR/CANR 2022), SCI or dysfunction quality of life rating scale (SCIDQLRS) (IANR 2022 version). Neurorestorative effects of varying therapeutic stra-tegies with higher standards of evidence-based medicine are now benefiting patients with currently incurable neurological diseases. Hopefully some of them may become routine therapeutic interventions for patients with these diseases in the near future.
|
|
| 13. |
- Ramstedt, Sofia, et al.
(författare)
-
DEATHSTAR: Nearby AGB stars with the Atacama Compact Array I. CO envelope sizes and asymmetries: A new hope for accurate mass-loss-rate estimates
- 2020
-
Ingår i: Astronomy and Astrophysics. - : EDP Sciences. - 0004-6361 .- 1432-0746. ; 640
-
Tidskriftsartikel (refereegranskat)abstract
- Context. This is the first publication from the DEATHSTAR project. The overall goal of the project is to reduce the uncertainties of the observational estimates of mass-loss rates from evolved stars on the Asymptotic Giant Branch (AGB). Aim. The aim in this first publication is to constrain the sizes of the (CO)-C-12 emitting region from the circumstellar envelopes around 42 mostly southern AGB stars, of which 21 are M-type and 21 are C-type, using the Atacama Compact Array (ACA) at the Atacama Large Millimeter/submillimeter Array. The symmetry of the outflows is also investigated. Methods. Line emission from (CO)-C-12 J = 2 -> 1 and 3 -> 2 from all of the sources were mapped using the ACA. In this initial analysis, the emission distribution was fit to a Gaussian distribution in the uv-plane. A detailed radiative transfer analysis will be presented in a future publication. The major and minor axis of the best-fit Gaussian at the line center velocity of the (CO)-C-12 J = 2 -> 1 emission gives a first indication of the size of the emitting region. Furthermore, the fitting results, such as the Gaussian major and minor axis, center position, and the goodness of fit across both lines, constrain the symmetry of the emission distribution. For a subsample of sources, the measured emission distribution is compared to predictions from previous best-fit radiative transfer modeling results. Results. We find that the CO envelope sizes are, in general, larger for C-type than for M-type AGB stars, which is as expected if the CO/H-2 ratio is larger in C-type stars. Furthermore, the measurements show a relation between the measured (Gaussian) (CO)-C-12 J = 2 -> 1 size and circumstellar density that, while in broad agreement with photodissociation calculations, reveals large scatter and some systematic differences between the different stellar types. For lower mass-loss-rate irregular and semi-regular variables of both M- and C-type AGB stars, the (CO)-C-12 J = 2 -> 1 size appears to be independent of the ratio of the mass-loss rate to outflow velocity, which is a measure of circumstellar density. For the higher mass-loss-rate Mira stars, the (CO)-C-12 J = 2 -> 1 size clearly increases with circumstellar density, with larger sizes for the higher CO-abundance C-type stars. The M-type stars appear to be consistently smaller than predicted from photodissociation theory. The majority of the sources have CO envelope sizes that are consistent with a spherically symmetric, smooth outflow, at least on larger scales. For about a third of the sources, indications of strong asymmetries are detected. This is consistent with what was found in previous interferometric investigations of northern sources. Smaller scale asymmetries are found in a larger fraction of sources. Conclusions. These results for CO envelope radii and shapes can be used to constrain detailed radiative transfer modeling of the same stars so as to determine mass-loss rates that are independent of photodissociation models. For a large fraction of the sources, observations at higher spatial resolution will be necessary to deduce the nature and origin of the complex circumstellar dynamics revealed by our ACA observations.
|
|
| 14. |
|
|
| 15. |
|
|
| 16. |
- Andriantsaralaza, Miora, et al.
(författare)
-
DEATHSTAR: Nearby AGB stars with the Atacama Compact Array: II. CO envelope sizes and asymmetries: The S-type stars
- 2021
-
Ingår i: Astronomy and Astrophysics. - : EDP Sciences. - 0004-6361 .- 1432-0746. ; 653
-
Tidskriftsartikel (refereegranskat)abstract
- Aims. We aim to constrain the sizes of, and investigate deviations from spherical symmetry in, the CO circumstellar envelopes (CSEs) of 16 S-type stars, along with an additional 7 and 4 CSEs of C-type and M-type AGB stars, respectively. Methods. We map the emission from the CO J = 2-1 and 3-2 lines observed with the Atacama Compact Array (ACA) and its total power (TP) antennas, and fit with a Gaussian distribution in the uv- and image planes for ACA-only and TP observations, respectively. The major axis of the fitted Gaussian for the CO(2-1) line data gives a first estimate of the size of the CO-line-emitting CSE. We investigate possible signs of deviation from spherical symmetry by analysing the line profiles and the minor-to-major axis ratio obtained from visibility fitting, and by investigating the deconvolved images. Results. The sizes of the CO-line-emitting CSEs of low-mass-loss-rate (low-MLR) S-type stars fall between the sizes of the CSEs of C-stars, which are larger, and those of M-stars, which are smaller, as expected because of the differences in their respective CO abundances and the dependence of the photodissociation rate on this quantity. The sizes of the low-MLR S-type stars show no dependence on circumstellar density, as measured by the ratio of the MLR to terminal outflow velocity, irrespective of variability type. The density dependence steepens for S-stars with higher MLRs. While the CO(2-1) brightness distribution size of the low-density S-stars is in general smaller than the predicted photodissociation radius (assuming the standard interstellar radiation field), the measured size of a few of the high-density sources is of the same order as the expected photodissociation radius. Furthermore, our results show that the CO CSEs of most of the S-stars in our sample are consistent with a spherically symmetric and smooth outflow. For some of the sources, clear and prominent asymmetric features are observed which are indicative of intrinsic circumstellar anisotropy. Conclusions. As the majority of the S-type CSEs of the stars in our sample are consistent with a spherical geometry, the CO envelope sizes obtained in this paper will be used to constrain detailed radiative transfer modelling to directly determine more accurate MLR estimates for the stars in our sample. For several of our sources that present signs of deviation from spherical symmetry, further high-resolution observations would be necessary to investigate the nature of, and the physical processes behind, these asymmetrical structures. This will provide further insight into the mass-loss process and its related chemistry in S-type AGB stars.
|
|
| 17. |
- Saberi, Maryam, 1988, et al.
(författare)
-
Detection of CI line emission towards the oxygen-rich AGB star omi Ceti
- 2018
-
Ingår i: Astronomy and Astrophysics. - : EDP Sciences. - 0004-6361 .- 1432-0746. ; 612
-
Tidskriftsartikel (refereegranskat)abstract
- We present the detection of neutral atomic carbon CI( 3 P 1 - 3 P 0 ) line emission towards omi Cet. This is the first time that CI is detected in the envelope around an oxygen-rich M-type asymptotic giant branch (AGB) star. We also confirm the previously tentative CI detection around V Hya, a carbon-rich AGB star. As one of the main photodissociation products of parent species in the circumstellar envelope (CSE) around evolved stars, CI can be used to trace sources of ultraviolet (UV) radiation in CSEs. The observed flux density towards omi Cet can be reproduced by a shell with a peak atomic fractional abundance of 2.4 × 10 -5 predicted based on a simple chemical model where CO is dissociated by the interstellar radiation field. However, the CI emission is shifted by ∼4 km s -1 from the stellar velocity. Based on this velocity shift, we suggest that the detected CI emission towards omi Cet potentially arises from a compact region near its hot binary companion. The velocity shift could, therefore, be the result of the orbital velocity of the binary companion around omi Cet. In this case, the CI column density is estimated to be 1.1 × 10 19 cm -2 . This would imply that strong UV radiation from the companion and/or accretion of matter between two stars is most likely the origin of the CI enhancement. However, this hypothesis can be confirmed by high-angular resolution observations.
|
|
| 18. |
|
|
| 19. |
|
|
| 20. |
- Tahmasian, Masoud, et al.
(författare)
-
ENIGMA-Sleep : Challenges, opportunities, and the road map
- 2021
-
Ingår i: Journal of Sleep Research. - : Wiley. - 0962-1105 .- 1365-2869. ; 30:6
-
Forskningsöversikt (refereegranskat)abstract
- Neuroimaging and genetics studies have advanced our understanding of the neurobiology of sleep and its disorders. However, individual studies usually have limitations to identifying consistent and reproducible effects, including modest sample sizes, heterogeneous clinical characteristics and varied methodologies. These issues call for a large-scale multi-centre effort in sleep research, in order to increase the number of samples, and harmonize the methods of data collection, preprocessing and analysis using pre-registered well-established protocols. The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium provides a powerful collaborative framework for combining datasets across individual sites. Recently, we have launched the ENIGMA-Sleep working group with the collaboration of several institutes from 15 countries to perform large-scale worldwide neuroimaging and genetics studies for better understanding the neurobiology of impaired sleep quality in population-based healthy individuals, the neural consequences of sleep deprivation, pathophysiology of sleep disorders, as well as neural correlates of sleep disturbances across various neuropsychiatric disorders. In this introductory review, we describe the details of our currently available datasets and our ongoing projects in the ENIGMA-Sleep group, and discuss both the potential challenges and opportunities of a collaborative initiative in sleep medicine.
|
|
